Amoeba SA
PAR:ALMIB

Watchlist Manager
Amoeba SA Logo
Amoeba SA
PAR:ALMIB
Watchlist
Price: 0.856 EUR 1.18% Market Closed
Market Cap: 44.2m EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

There is not enough data to reliably calculate the relative value of ALMIB.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALMIB Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

N/A
P/S
P/S
Price to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
1.5
Forward
71.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-3.6
Industry
21.6
Forward
-5.3
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-6.1
Median 5Y
-7.1
Industry
13.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-3.5
Industry
21.6
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
16
Median 3Y
-2.9
Median 5Y
4.8
Industry
1.7
More Details
N/A
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
1.7
Forward
88.4
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
-75.2
Median 5Y
-82.7
Industry
7.1
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-4.4
Median 5Y
-5.8
Industry
13.1
Forward
-8.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-4.7
Industry
17.8
Forward
-7.4
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-5.6
Median 5Y
-6.4
Industry
14.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-5.8
Industry
20.8
More Details
13.2
EV/IC
EV/IC
Enterprise Value to IC
13.2
vs History
11
vs Industry
2
Median 3Y
5.4
Median 5Y
5.1
Industry
1.3
More Details

Multiples Across Competitors

ALMIB Competitors Multiples
Amoeba SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Amoeba SA
PAR:ALMIB
40.7m EUR 0 -6.4 -10.3 -8.8
US
Sherwin-Williams Co
NYSE:SHW
84.1B USD 3.7 31.4 21.2 24.7
US
Ecolab Inc
NYSE:ECL
75.1B USD 4.8 35.7 22.5 30.4
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
8.2T JPY 3.2 16 7.4 9.9
CH
Givaudan SA
SIX:GIVN
31.8B CHF 4.3 29.1 19.8 24.9
US
Dupont De Nemours Inc
NYSE:DD
30.7B USD 2.4 -407.8 10.2 15.8
CN
Wanhua Chemical Group Co Ltd
SSE:600309
200.4B CNY 1.1 16.8 17.5 17.5
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.3T INR 6.8 63.2 38 45.8
CH
DSM-Firmenich AG
AEX:DSFIR
22.5B EUR 1.8 89.9 12.2 43.2
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK 9.3 54.8 28.9 37.9
US
PPG Industries Inc
NYSE:PPG
24.6B USD 1.6 22.4 12.4 15.6
P/E Multiple
Earnings Growth PEG
FR
Amoeba SA
PAR:ALMIB
Average P/E: 39.9
Negative Multiple: -6.4 		N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
31.4
12%
2.6
US
Ecolab Inc
NYSE:ECL
35.7
10%
3.6
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
16
N/A N/A
CH
Givaudan SA
SIX:GIVN
29.1
8%
3.6
US
Dupont De Nemours Inc
NYSE:DD
Negative Multiple: -407.8
47%
N/A
CN
Wanhua Chemical Group Co Ltd
SSE:600309
16.8
13%
1.3
IN
Asian Paints Ltd
NSE:ASIANPAINT
63.2
14%
4.5
CH
D
DSM-Firmenich AG
AEX:DSFIR
89.9
77%
1.2
DK
Novozymes A/S
CSE:NZYM B
54.8
N/A N/A
US
PPG Industries Inc
NYSE:PPG
22.4
25%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Amoeba SA
PAR:ALMIB
Average EV/EBITDA: 19
Negative Multiple: -10.3 		N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
21.2
9%
2.4
US
Ecolab Inc
NYSE:ECL
22.5
9%
2.5
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
7.4
6%
1.2
CH
Givaudan SA
SIX:GIVN
19.8
6%
3.3
US
Dupont De Nemours Inc
NYSE:DD
10.2
8%
1.3
CN
Wanhua Chemical Group Co Ltd
SSE:600309
17.5
31%
0.6
IN
Asian Paints Ltd
NSE:ASIANPAINT
38
10%
3.8
CH
D
DSM-Firmenich AG
AEX:DSFIR
12.2
11%
1.1
DK
Novozymes A/S
CSE:NZYM B
28.9
N/A N/A
US
PPG Industries Inc
NYSE:PPG
12.4
5%
2.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Amoeba SA
PAR:ALMIB
Average EV/EBIT: 26.6
Negative Multiple: -8.8 		N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
24.7
10%
2.5
US
Ecolab Inc
NYSE:ECL
30.4
11%
2.8
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
9.9
N/A N/A
CH
Givaudan SA
SIX:GIVN
24.9
7%
3.6
US
Dupont De Nemours Inc
NYSE:DD
15.8
18%
0.9
CN
Wanhua Chemical Group Co Ltd
SSE:600309
17.5
8%
2.2
IN
Asian Paints Ltd
NSE:ASIANPAINT
45.8
10%
4.6
CH
D
DSM-Firmenich AG
AEX:DSFIR
43.2
412%
0.1
DK
Novozymes A/S
CSE:NZYM B
37.9
N/A N/A
US
PPG Industries Inc
NYSE:PPG
15.6
6%
2.6

See Also

Summary
ALMIB intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALMIB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALMIB stock valuation using valuation multiples.
Wall Street Estimates
ALMIB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALMIB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 271,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.